¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"IMM"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • immunologic intervention
    ¸é¿ªÇÐÁ¶Á¤
  • immunologic memory
    ¸é¿ª±â¾ï
  • immunologic pregnancy test
    ¸é¿ªÀӽŹÝÀÀ°Ë»ç
  • immunologic technique
    ¸é¿ªÇÐÀû±â¼ú
  • immunologic tolerance
    ¸é¿ªÇã¿ë
  • immunological
    ¸é¿ªÇÐÀû-
  • immunological adjuvant
    ¸é¿ªº¸°­Á¦
  • immunological disease
    ¸é¿ªº´, ¸é¿ªÁúȯ
  • immunological incompetence
    ¸é¿ªºÎÀü
  • immunological recognition
    ¸é¿ªÀνÄ
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • immunological unresponsiveness
    ¸é¿ª¹«¹ÝÀÀ
  • immunologically competent cell
    ¸é¿ª¼¼Æ÷
  • immunologist
    ¸é¿ªÇÐÀÚ
  • immunology
    ¸é¿ªÇÐ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • immunologic memory
    ¸é¿ª±â¾ï
  • immunologic reaction
    (¢¡immune) ¸é¿ª¹ÝÀÀ
  • immunologic technique
    ¸é¿ªÇÐÀû±â¼ú
  • immunologic tolerance
    ¸é¿ª°ü¿ë
  • immunological
    ¸é¿ªÇÐÀû-
  • immunological absorbent
    ¸é¿ªÈíÂøÁ¦
  • immunological adjuvant
    ¸é¿ªº¸°­Á¦
  • immunological competence
    ¸é¿ªÀû°Ý¼º
  • immunological disease
    ¸é¿ªÁúȯ
  • immunological incompetence
    ¸é¿ªºÎÀü
  • immunological reaction
    (¢¡immune) ¸é¿ª¹ÝÀÀ
  • immunological recognition
    ¸é¿ªÀÎÁö
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • immunological unresponsiveness
    ¸é¿ª¹«¹ÝÀÀ
  • immunologically competent cell
    (¢¡immunocyte) ¸é¿ª¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • immunity, tissue
    Á¶Á÷¸é¿ª
  • immunity, transplantation
    À̽ĸ鿪
  • immunity,cell-mediated
    ¼¼Æ÷¸Å°³¼º(á¬øàØÚË¿àõ)
  • immunity,humoral
    ü¾×¼º
  • immunization
    ¸é¿ª(¹ý)
  • immunization
    ¸é¿ª(¹ý), ¿¹¹æÁ¢Á¾(ËçËÑËøÌ¡).
  • immunization
    ¸é¿ª(¹ý), ¿¹¹æÁ¢Á¾(çãÛÁïÈðú).
  • immunization therapy
    ¸é¿ª¿ä¹ý(Øóæ¹èþÛö).
  • immunization therapy
    ¸é¿ª¿ä¹ý(¸é¿ª¿ä¹ý).
  • immunization, active
    ´Éµ¿¸é¿ª, ´Éµ¿¸é¿ªÁ¶Ä¡
  • immunization, passive
    ¼öµ¿¸é¿ª
  • immunization, prophylactic
    ¿¹¹æ¸é¿ª
  • immunize
    ¸é¿ª½ÃŰ´Ù.
  • immunizing dose
    ¸é¿ª·®(Øóæ¹åÖ).
  • immunizing unit
    ¸é¿ª´ÜÀ§(¡­Ó¤êÈ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • immunity
    ¸é¿ª,(Øóæ¹)
  • immunity
    ¸é¿ª(¼º)
  • immunity deficiency =immunodeficiency
    ¸é¿ª°áÇÌ(¡­ÌÀù¹).
  • immunity pattern
    ¸é¿ª¾ç½Ä, ¸é¿ªÇü.
  • immunity ³ª immunitas
    ¸é¿ª(¼º)(Øóæ¹àõ).
  • immunity, acquired
    ȹµæ¸é¿ª, ÈÄõ¼º¸é¿ª
  • immunity, active
    ´Éµ¿¸é¿ª
  • immunity, adoptive
    ÀÔ¾ç¸é¿ª, ÀÌÀԸ鿪
  • immunity, antibacterial
    Çױո鿪
  • immunity, antitoxic
    Ç×µ¶¼Ò¸é¿ª
  • immunity, antitumor
    Ç×Á¾¾ç¸é¿ª
  • immunity, antiviral
    Ç×¹ÙÀÌ·¯½º¸é¿ª
  • immunity, cell-mediated
    ¼¼Æ÷¸Å°³¸é¿ª
  • immunity, cellular
    ¼¼Æ÷¸Å°³¸é¿ª
  • immunity, concomitant
    ¼ö¹Ý¸é¿ª, ºÎ¼ö¸é¿ª
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
immunochemotherapy <immunology, oncology> The use of a combination of immune system therapy and chemotherapeutic drugs to treat cancer.
(09 Oct 1997)
immunocompetant Able to develop an immune response. The opposite of immunodeficient.
(12 Dec 1998)
immunocompetence <immunology> The bodys ability to develop an immune response to infection or disease. Immunocompetence is measured to see how well the body can fight off certain disease. Many cancer patients become immunocompromised, where their immune system is not as strong as a healthy person's.
(16 Dec 1997)
immunocompetent Able to recognise and act against invading antigens.
(09 Oct 1997)
immunocomplex Complexes of antibody and antigen.
See: immune complex.
(05 Mar 2000)
immunocompromised A condition in which the immune system is not functioning normally.
(16 Dec 1997)
immunocompromised host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
(12 Dec 1998)
immunoconglutinin <protein> Antibodies that react with complement components or their breakdown products. Usually directed against C3b or C4 and found in high titre in patients with rheumatoid arthritis. They are formed in response to infection or injection of antigens.
(14 Oct 1997)
immunoconjugates Combinations of diagnostic or therapeutic substances linked with specific immune substances such as immunoglobulins, monoclonal antibodies or antigens. Often the diagnostic or therapeutic substance is a radionuclide. These conjugates are useful tools for specific targeting of drugs and radioisotopes in the chemotherapy and radioimmunotherapy of certain cancers.
(12 Dec 1998)
immunocyte <haematology, immunology> A leukocyte that is able to stage an immune response.
(09 Oct 1997)
immunocytoadherence <technique> A method for determining cell surface properties, in which immunoglobulin or receptors on the surface of one cell population cause cells with corresponding molecular configurations on their surface to adhere in rosettes around the cells.
A process through which specific antibody-forming cells bind to antigenicparticles, forming clusters.
(21 Jun 2000)
immunocytochemical assay Involves the computerised assessment of microscopic fields following direct fluorescent antibody, indirect fluorescent antibody or indirect or direct immunoperoxidase analysis of biopsy tissue from the patient. In addition to improved specificity with the removal of operator subjectivity, the quantifiability of results through computer data analysis of colour, intensity and concentration has only begun to be realised.
(05 Mar 2000)
immunocytochemistry <technique> Techniques for staining cells or tissues using antibodies against the appropriate antigen. Although in principle the first antibody could be labelled, it is more common (and improves the visualisation) to use a second antibody directed against the first (an antiIgG). This second antibody is conjugated either with fluorochromes or appropriate enzymes for colourimetric reactions or gold beads (for electron microscopy) or with the biotin avidin system, so that the location of the primary antibody and thus the antigen, can be recognised.
(18 Nov 1997)
immunodeficiency Inabillity to mount a normal immune response. Immunodeficiency can be due to a genetic disease or acquired as in aids due to HIV.
(12 Dec 1998)
immunodeficiency disorders <radiology> B-cell (antibody) deficiency: high-grade pathogens: pneumococcus, strep, H. Flu, chronic sinopulmonary disease, usual survival to adulthood, T-cell (cellular) deficiency: low-grade pathogens: fungi, viruses, Pneumocystic, growth retardation, diarrhoea, delayed anergy, short life-span, susceptible to graft vs. Host (GvH) disease, e.g.: DiGeorge syndrome, Nezelhof syndrome Note: increased risk of malignancy
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 11
  • Immunoglobulin Fc Fragments - »õâ Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN.
    Synonyms : Immunoglobulin Fc Fragment, Immunoglobulins, Fc, Immunoglobulins, Fc Fragment, Fc Fragment Immunoglobulins, Fc Fragment, Immunoglobulin, Fc Fragments, Immunoglobulin, Fragment Immunoglobulins, Fc
  • Immunoglobulin Fragments - »õâ Partial immunoglobulin molecules resulting from selective cleavage by proteolytic enzymes or generated through PROTEIN ENGINEERING techniques.
    Synonyms : Fragments, Immunoglobulin
  • Immunoglobulin G - »õâ The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
    Synonyms : Allerglobuline, IgG(T), IgG1, IgG2, IgG2A, IgG2B, IgG3, IgG4, Immunoglobulin GT, Polyglobin, 7S Gamma Globulin, GT, Immunoglobulin
  • Immunoglobulin gamma-Chains - »õâ Heavy chains of IMMUNOGLOBULIN G having a molecular weight of approximately 51 kDa. They contain about 450 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the Fc fragment constant region. The gamma heavy chain subclasses (for example, gamma 1, gamma 2a, and gamma 2b) of the IMMUNOGLOBULIN G isotype subclasses (IgG1, IgG2A, and IgG2B) resemble each other more closely than the heavy chains of the other IMMUNOGLOBULIN ISOTYPES.
    Synonyms : Immunoglobulin gamma-Chain, gamma Immunoglobulin Heavy Chain, gamma Immunoglobulin Heavy Chains, gamma-1-Immunoglobulin Heavy Chain, gamma-2a-Immunoglobulin Heavy Chain, gamma-2b-Immunoglobulin Heavy Chain, gamma-Chain Immunoglobulins
  • Immunoglobulin Gm Allotypes - »õâ Allelic variants of the gamma-immunoglobulin heavy chain (IMMUNOGLOBULIN GAMMA-CHAINS) encoded by ALLELES of IMMUNOGLOBULIN HEAVY CHAIN GENES.
    Synonyms : Allotype, Gm, Allotype, Immunoglobulin Gm, Allotypes, Gm, Gm Allotype, Gm Allotype, Immunoglobulin, Gm Allotypes, Immunoglobulin, Immunoglobulin Gm Allotype
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
immunoglobulin E one of the five major classes of immunoglobulins; present primarily in the skin and mucous membranes
Ãâó: wordnet.princeton.edu/perl/webwn
immunosuppressive immunosuppressant: a drug that lowers the body's normal immune response
Ãâó: wordnet.princeton.edu/perl/webwn
immunoglobulin G one of the five major classes of immunoglobulins; the main antibody defense against bacteria
Ãâó: wordnet.princeton.edu/perl/webwn
immunoglobulin M one of the five major classes of immunoglobulins; involved in fighting blood infections and in triggering production of immunoglobulin G
Ãâó: wordnet.princeton.edu/perl/webwn
immature characteristic of a lack of maturity; "immature behavior" lacking in development; "immature plans"; "an unformed character" young: (used of living things especially persons) in an early period of life or development or growth; "young people" green: not fully developed or mature; not ripe; "unripe fruit"; "fried green tomatoes"; "green wood" not yet mature unfledged: (of birds) not yet having developed feathers; "a small unfledged sparrow on the window sill"
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • immunogentics
    (´Ü¼ö Ãë±Þ)¸é¿ª À¯ÀüÇÐ
  • immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°
  • immunohematology
    ¸é¿ª Ç÷¾×ÇÐ
  • immunologicalm surveillancd
    (ÀÎüÁ¶Á÷ÀÇ)¸é¿ª °¨½Ã(±â±¸)
  • immunology
    ¸é¿ªÇÐ;-gist
  • immunoprotein
    (»ýÈ­)¸é¿ª´Ü¹éÁú(¸é¿ª ±Û·Îºí¸°,ÀÎÅÍÆä·Ðµî)
  • immunoreactive
    ¸é¿ª¹ÝÀÀ¼ºÀÇ
  • immunoregulation
    (ÀÇ)¸é¿ª Á¶Á¤
  • immunosuppressant
    °ÅºÎ ¹ÝÀÀ ¾ïÁ¦ÀÇ
  • immunosuppressant
    IMMUNOSUPPRESSIVE
  • immunosuppression
    (ÀÇ)¸é¿ª¾ïÁ¦
  • immunosuppressive
    °ÅºÎ ¹ÝÀÀ ¾ïÁ¦ÀÇ
  • immunosuppressive
    (ÀÇ)¸é¿ª(¹ÝÀÀ)¾ïÁ¦¾à(¹°Áú);¸é¿ª(¹ÝÀÀ);¾ïÁ¦(¼º)ÀÇ
  • immunosurveillance
    IMMUNOLOGICAL SURVEILLANCE
  • immunotherapy
    (ÀÇ)¸é¿ª¿ä¹ý;¸é¿ªÁ¦ Ä¡·á¹ý
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 11
IMM not adhering to ethical or moral principles
IMM morally objectionable behavior
IMM the quality of not being in accord with standards of right or good conduct
IMM without regard for morality
IMM any supernatural being worshipped as controlling some part of the world or some aspect of life or who is the personification of a force
IMM a person (such as an author) of enduring fame
IMM not subject to death
IMM make famous for ever
IMM be or provide a memorial to a person or an event
IMM the quality or state of being immortal
IMM perpetual life after death
IMM make famous for ever
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 11
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á